Immix Biopharma, Inc. (IMMX)
$13.61-0.37%Close
BUYRECOVERY · day 15
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $740M
- Avg volume
- 1.6M
- Beta
- 0.11
- P/E (TTM)
- -15.47
- Short % float
- 21.87%
- Days to cover
- 5.2
- SI change
- +11.7%
- 1W
- +20.02%
- 1M
- +59.74%
- 3M
- +55.01%
- YTD
- +150.64%
- vs SPY 1W
- +21.21%
- vs SPY 1M
- +56.42%
- vs SPY 3M
- +52.62%
- vs SPY YTD
- +138.89%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- AURABUYAura Biosciences, Inc.RECOVERYQ -3$7.90+1.28%
- AVBPSELLArriVent BioPharma, Inc. Common StockRECOVERYQ 21$28.26-2.95%
- AVLNBUYAvalyn Pharma Inc. Common StockQ 75$37.69-1.77%
- CLYMBUYClimb Bio, Inc.BULLQ 11$16.40-5.09%
- COAGBUYHemab Therapeutics Holdings, Inc. Common StockQ 70$46.67-5.07%
- DFTXSELLDefinium Therapeutics, Inc.RECOVERYQ 27$43.27-3.65%
- ELDNSELLEledon Pharmaceuticals, Inc.RECOVERYQ -11$3.41-1.16%
- ELVNBUYEnliven Therapeutics, Inc.BULLQ 15$61.15+2.22%
- EPRXBUYEupraxia Pharmaceuticals Inc.RECOVERYQ 46$7.28+8.17%
- GHRSBUYGH Research PLCBEARQ 19$28.10-0.81%
- GPCRBUYStructure Therapeutics Inc.RECOVERYQ 27$49.01-0.16%
- IRONBUYDisc Medicine, Inc.RECOVERYQ 4$80.94+1.42%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
